Pfizer Inc. (PFE) is expected to report earnings on Tuesday, November 3, 2026, after the close. Estimated release time 07:05 ET. Consensus EPS estimate is $0.79.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-08-04 | FY2026 Q2 | $0.68 | $0.77 | +12.9% | $15.03B |
| 2026-05-05 | FY2026 Q1 | $0.72 | $0.75 | +3.9% | $14.45B |
| 2026-02-26 | FY2025 Q4 | $0.57 | $0.66 | +16.4% | $17.56B |
| 2025-11-04 | FY2025 Q3 | $0.63 | $0.62 | -2.1% | $16.65B |
| 2025-08-05 | FY2025 Q2 | $0.58 | $0.51 | -12.1% | $14.65B |
| 2025-05-05 | FY2025 Q1 | $0.67 | $0.52 | -21.5% | $13.71B |
| 2025-02-27 | FY2024 Q4 | $0.47 | $0.63 | +33.6% | $17.76B |
| 2024-11-04 | FY2024 Q3 | $0.61 | $0.79 | +28.6% | $17.70B |
PFE has beaten consensus EPS in 5 of its last 8 reported quarters.
See PFE on the live calendar →